Article Information
History
- January 25, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Madison Stoddard1,
- Lin Yuan1,
- Sharanya Sarkar2,
- Matthew Mazewski3,
- Debra van Egeren4,
- Shruthi Mangalaganesh5,
- Ryan P. Nolan6,
- Michael S. Rogers7,8,
- Greg Hather9,
- Laura F. White10 and
- Arijit Chakravarty1,*
- 1Fractal Therapeutics, Cambridge, MA, USA
- 2Dartmouth College, Hanover, NH, USA
- 3Independent Researcher
- 4Stanford University School of Medicine, Stanford, CA, USA
- 5Monash University, Melbourne, VIC, AUS
- 6Halozyme Therapeutics, San Diego, CA, USA
- 7Harvard Medical School, Boston, MA, USA
- 8Boston Children’s Hospital, Boston, MA, USA
- 9Sage Therapeutics, Cambridge, MA, USA
- 10Boston University School of Public Health, Boston, MA, USA
- ↵*Corresponding author Email: arijit{at}fractal.tx (A.C.)